38 related articles for article (PubMed ID: 15719385)
1. Leukocyte depletion for safe blood transfusion.
Singh S; Kumar A
Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
[TBL] [Abstract][Full Text] [Related]
2. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter.
Kim JM; Kim GS; Joh JW; Suh KS; Park JB; Ko JS; Kwon CH; Yi NJ; Gwak MS; Lee KW; Kim SJ; Lee SK
Transpl Int; 2013 Jan; 26(1):84-9. PubMed ID: 23194351
[TBL] [Abstract][Full Text] [Related]
3. Blood Salvage and Autotransfusion With Single Leukoreduction Does Not Increase the Risk of Tumor Recurrence After Liver Transplantation for Advanced Hepatocellular Carcinoma.
Kwon JH; Han S; Kim D; Kuk JH; Cho H; Kim S; Yang JD; Kim C; Kim JM; Choi GS; Joh JW; Ko JS; Gwak MS; Kim G
Ann Surg; 2022 Dec; 276(6):e842-e850. PubMed ID: 33914466
[TBL] [Abstract][Full Text] [Related]
4. Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.
Kwon JH; Han S; Jang JS; Lee KW; Ahn JH; Kim K; Jeon S; Gwak MS; Ko JS; Kim GS; Joh JW; Cho D
Transplantation; 2021 Mar; 105(3):577-585. PubMed ID: 32265418
[TBL] [Abstract][Full Text] [Related]
5. Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma.
Han S; Kim G; Ko JS; Sinn DH; Yang JD; Joh JW; Lee SK; Gwak MS
Ann Surg; 2016 Aug; 264(2):339-43. PubMed ID: 26501715
[TBL] [Abstract][Full Text] [Related]
6. Reduction of EpCAM-Positive Cells from a Cell Salvage Product Is Achieved by Leucocyte Depletion Filters Alone.
Merolle L; Schiroli D; Farioli D; Razzoli A; Gavioli G; Iori M; Piccagli V; Lambertini D; Bassi MC; Baricchi R; Marraccini C
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373781
[TBL] [Abstract][Full Text] [Related]
7. Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis.
Wang Z; Li S; Jia Y; Liu M; Yang K; Sui M; Liu D; Liang K
Front Oncol; 2022; 12():985281. PubMed ID: 36330502
[TBL] [Abstract][Full Text] [Related]
8. The liver-resident immune cell repertoire - A boon or a bane during machine perfusion?
Fodor M; Salcher S; Gottschling H; Mair A; Blumer M; Sopper S; Ebner S; Pircher A; Oberhuber R; Wolf D; Schneeberger S; Hautz T
Front Immunol; 2022; 13():982018. PubMed ID: 36311746
[TBL] [Abstract][Full Text] [Related]
9. Removal of EpCAM-positive tumor cells from blood collected during major oncological surgery using the Catuvab device- a pilot study.
Winter A; Zacharowski K; Meybohm P; Schnitzbauer A; Ruf P; Kellermann C; Lindhofer H
BMC Anesthesiol; 2021 Oct; 21(1):261. PubMed ID: 34715784
[TBL] [Abstract][Full Text] [Related]
10. French editorial from the ACHBPT: blood salvage and autotransfusion during liver transplantation for advanced hepatocellular carcinoma.
Maulat C; Boulard P; Muscari F
Hepatobiliary Surg Nutr; 2021 Jun; 10(3):367-369. PubMed ID: 34159164
[No Abstract] [Full Text] [Related]
11. CTCs detection from intraoperative salvaged blood in RCC-IVC thrombus patients by negative enrichment and iFISH identification: a preliminary study.
Zhang X; Guo X; Zong Y; Xu C; Wang J; Zhang B; Liu C; Gong Y; Xue L; Ma L; Zhang S; Li Y; Zeng H
BMC Urol; 2021 Jun; 21(1):89. PubMed ID: 34112129
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of riboflavin photochemical treatment for inactivation of HCT116 tumor cells mixed in simulative intraoperative salvage blood.
Yu Y; Yang L; He C; Tai S; Ma C; Yang T; Wang D
Transfusion; 2019 Oct; 59(10):3205-3213. PubMed ID: 31571260
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of intraoperative blood salvage for patients with malignancy disease: A PRISMA-compliant systematic review and meta-analysis.
Wu WW; Zhang WY; Zhang WH; Yang L; Deng XQ; Ou MC; Yang YX; Liu HB; Zhu T
Medicine (Baltimore); 2019 Jul; 98(27):e16040. PubMed ID: 31277097
[TBL] [Abstract][Full Text] [Related]
14. Effect of X-ray irradiation on hepatocarcinoma cells and erythrocytes in salvaged blood.
Zhang FJ; Yang JT; Tang LH; Wang WN; Sun K; Ming Y; Muhammad KG; Zheng YF; Yan M
Sci Rep; 2017 Aug; 7(1):7995. PubMed ID: 28801583
[TBL] [Abstract][Full Text] [Related]
15. Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery?
Kumar N; Ahmed Q; Lee VK; Zaw AS; Goy R; Wong HK
Eur Spine J; 2016 Dec; 25(12):3997-4007. PubMed ID: 26188770
[TBL] [Abstract][Full Text] [Related]
16. Irradiation Can Selectively Kill Tumor Cells while Preserving Erythrocyte Viability in a Co-Culture System.
Gong M; Yang JT; Liu YQ; Tang LH; Wang Y; Wang LJ; Zhang FJ; Yan M
PLoS One; 2015; 10(5):e0127181. PubMed ID: 26018651
[TBL] [Abstract][Full Text] [Related]
17. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients.
Akbulut S; Kayaalp C; Yilmaz M; Ince V; Ozgor D; Karabulut K; Eris C; Toprak HI; Aydin C; Yilmaz S
World J Gastroenterol; 2013 Mar; 19(10):1625-31. PubMed ID: 23538988
[TBL] [Abstract][Full Text] [Related]
18. Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells?
Gwak MS; Lee KW; Kim SY; Lee J; Joh JW; Kim SJ; Lee HH; Park JW; Kim GS; Lee SK
Liver Transpl; 2005 Mar; 11(3):331-5. PubMed ID: 15719385
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
